Search Results
Results found for "Radionetics"
- Crinetics Pharmaceuticals announced the formation of an independently operated new company...
December 2021 Crinetics Pharmaceuticals announced the formation of an independently operated new company, Radionetics Radionetics aims to develop a deep pipeline of novel, targeted, nonpeptide radiopharmaceuticals for the Crinetics’ Core Nonpeptide Platform and Includes Drug Candidates and Leads Against 10 Oncology Targets – Radionetics Frazier Healthcare Partners, today announced the formation of an independently operated new company, Radionetics Radionetics aims to develop a deep pipeline of novel, targeted, nonpeptide radiopharmaceuticals for the
- 📰 GPCR Weekly News, June 24 to 30, 2024
heart failure drug following reverse merger with Avrobio Lilly signs $140M upfront partnership with Radionetics
- Radioligands vs. Fluorescent Ligands: Binding Assays
They are ligands labeled with radioactive isotopes which can be used in binding assays to quantify other Another common radioactive atom, 125I, with a higher specific activity, but a shorter half-life (60 days
- Signals in Motion: Pain, Metabolism & Terry’s Corner
Learn how these tools help retain assay integrity while eliminating radioactivity—perfect for next-gen
- Dr. GPCR and Celtarys Research Join Forces to Expand Access to Innovative GPCR Tools
high-quality, fluorescently labeled ligands and innovative chemical biology tools to support real-time, non-radioactive
- Pharmacology at Your Fingertips: Terry’s Corner Launches
With nanomolar affinity, high specificity, and a strong signal-to-noise profile, this non-radioactive
- A robust and Efficient FRET-Based Assay for Cannabinoid Receptor Ligands Discovery.
The most used probe right now is the radioactive CP-55940, [3H-CP-55940].[11] Figure 1.
